Biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders

NZ792807BActive Publication Date: 2026-09-01TRAVERE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ792807
Authority / Receiving Office
NZ · NZ
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-11-16
Filing Date
2017-10-13
Publication Date
2026-09-01
Estimated Expiration
2037-10-13

Smart Images

  • Figure 1_ABST
    Figure 1_ABST
Patent Text Reader

Abstract

Methods of treating focal segmental glomerulosclerosis (FSGS) comprising administering a compound having structure (I) or a pharmaceutically acceptable salt thereof, or administering a pharmaceutical composition comprising the compound of structure (I) or pharmaceutically acceptable salt thereof, are provided. The escalating dose is sufficient to baseline reduce urine protein / creatinine above 1.5 g / g by 40% or more.
Need to check novelty before this filing date? Find Prior Art